Cerebrospinal tau, phospho-tau, and beta-amyloid and neuropsychological functions in Alzheimer's and Parkinson's disease

被引：0
|
作者：
Stefanova, E. [1 ]
Markovic, I. [2 ]
Mandic-Stojmenovic, G. [1 ]
Stojkovic, T. [1 ]
Lukic, M. Jecmenica [1 ]
Kostic, V. [1 ]
机构：
[1] Inst Neurol, Belgrade, Serbia
[2] Inst Biochem, Belgrade, Serbia
来源：
EUROPEAN JOURNAL OF NEUROLOGY | 2010年 / 17卷
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
引用
收藏
页码：351 / 351
页数：1
相关论文
共 50 条
  • [1] Cerebrospinal Tau, Phospho-Tau, and Beta-Amyloid and Neuropsychological Functions in Parkinson's Disease
    Compta, Yaroslau
    Marti, Maria J.
    Ibarretxe-Bilbao, Naroa
    Junque, Carme
    Valldeoriola, Francesc
    Munoz, Esteban
    Ezquerra, Mario
    Rios, Jose
    Tolosa, Eduardo
    [J]. MOVEMENT DISORDERS, 2009, 24 (15) : 2203 - 2210
  • [2] Tau, phospho-tau and Ab42 in cerebrospinal fluid in Alzheimer's disease
    Blennow, K
    [J]. EUROPEAN PSYCHIATRY, 2002, 17 : 77S - 77S
  • [3] Amyloid β (Aβ) and phospho-tau (p-tau) as diagnostic biomarkers in Alzheimer's disease
    Prvulovic, David
    Hampel, Harald
    [J]. CLINICAL CHEMISTRY AND LABORATORY MEDICINE, 2011, 49 (03) : 367 - 374
  • [4] Increased beta-amyloid and phospho-tau in diabetic encephalopathy
    Li, Zhen-Guo
    Zhang, Weixian
    Sima, Anders A. F.
    [J]. DIABETES, 2006, 55 : A190 - A190
  • [5] Beta-Amyloid, Phospho-Tau and Alpha-Synuclein Deposits Similar to Those in the Brain Are Not Identified in the Eyes of Alzheimer's and Parkinson's Disease Patients
    Ho, Cheng-Ying
    Troncoso, Juan C.
    Knox, David
    Stark, Walter
    Eberhart, Charles G.
    [J]. BRAIN PATHOLOGY, 2014, 24 (01) : 25 - 32
  • [6] Cerebrospinal fluid phospho-tau, total tau and β-amyloid1-42 in the differentiation between Alzheimer's disease and vascular dementia
    Nägga, K
    Gottfries, J
    Blennow, K
    Marcusson, J
    [J]. DEMENTIA AND GERIATRIC COGNITIVE DISORDERS, 2002, 14 (04) : 183 - 190
  • [7] CSF markers for Alzheimer's disease:: Total Tau, phospho-tau and Aβ42
    Andreasen, N
    Sjögren, M
    Blennow, K
    [J]. WORLD JOURNAL OF BIOLOGICAL PSYCHIATRY, 2003, 4 (04): : 147 - 155
  • [8] Tau and phospho-tau cerebrospinal levels correlate with temporal and frontal gray matter reduction in Parkinson's disease and Parkinson's disease with dementia
    Compta, Y.
    Ibarretxe-Bilbao, N.
    Junque, C.
    Bargallo, N.
    Braga-Pereira, J.
    Valldeoriola, F.
    Munoz, E.
    Tolosa, E.
    Marti, M. J.
    [J]. MOVEMENT DISORDERS, 2009, 24 : S295 - S295
  • [9] Cerebrospinal fluid biomarkers for diagnosis of Alzheimer's disease: Beta-amyloid(1-42), tau, phospho-tau-181 and total protein
    Marksteiner, Josef
    Hinterhuber, Hartmann
    Humpel, Christian
    [J]. DRUGS OF TODAY, 2007, 43 (06) : 423 - 431
  • [10] Brain Metabolic Correlates of Cerebrospinal Fluid Beta-Amyloid 42 and Tau in Alzheimer's Disease
    Vukovich, Ruth
    Perneczky, Robert
    Drzezga, Alexander
    Foerstl, Hans
    Kurz, Alexander
    Riemenschneider, Matthias
    [J]. DEMENTIA AND GERIATRIC COGNITIVE DISORDERS, 2009, 27 (05) : 474 - 480
12345